483
Kyle Coleman, M.D.Kyle Coleman, M.D. – FDA 483, Mar 20, 2019
Record Details
An FDA inspection of Kyle M. Coleman, MD, PI, a clinical investigator in New Orleans, LA, conducted from March 18-20, 2019, identified a significant deficiency in investigational drug disposition records. The firm failed to maintain adequate records regarding the dates and quantities of investigational drug product returned by subjects. This indicates a lack of proper accountability for investigational products during the clinical trial.
View Company Profile
ID · 1cca5eb9-369e-4fbb-8c01-e1af645ea298
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.